Brain Death: Inflammatory Response, Apoptosis, and Endotoxin Tolerance

This study has been completed.
Sponsor:
Information provided by:
Delafontaine Hospital
ClinicalTrials.gov Identifier:
NCT00615225
First received: February 4, 2008
Last updated: February 13, 2008
Last verified: February 2008
  Purpose

We hypothesized that brain death is associated with an early systemic inflammatory response, possibly combined with activation of apoptotic cell death, two events that may contribute to induce rapid organ dysfunction. In this study of brain-dead donors and controls, we assayed plasma cytokines and soluble factors, investigated plasma endotoxin levels as a triggering factor for inflammation, measured ex vivo cytokine production by blood leukocytes to determine whether immunosuppression occurred after brain death, and examined skeletal muscle biopsies to look for evidence of inflammation and increased apoptosis in peripheral tissue.


Condition Intervention
Brain Death
Procedure: Muscle biopsy

Study Type: Observational
Official Title: Observational Study on the Systemic Inflammatory Response During Brain Death.

Further study details as provided by Delafontaine Hospital:

Study Start Date: January 2000
Study Completion Date: December 2007
Primary Completion Date: November 2007 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Brain dead patients
All patients meeting criteria for brain death
Procedure: Muscle biopsy
Muscle biopsies were taken through the operation site from the vastus lateralis thigh muscle at the beginning of surgery
Healthy control
Any healthy volunteers accepting to give some blood
Volunteers having hip surgery
Patients undergoing hip surgery for degenerative non-inflammatory hip disease
Procedure: Muscle biopsy
Muscle biopsies were taken through the operation site from the vastus lateralis thigh muscle at the beginning of surgery

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Any brain dead patients diagnosed in three different ICUs

Criteria

Inclusion Criteria:

  • All brain dead patients whatever the cause (cardiac arrest, stroke, head trauma)

Exclusion Criteria:

  • Age < 18years
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00615225

Locations
Belgium
Liege Hospital
Liege, Belgium
France
Tenon Hospital
Paris, France, 75020
Delafontaine Hospital
Saint Denis, France, 93205
Sponsors and Collaborators
Delafontaine Hospital
Investigators
Principal Investigator: Christophe Adrie, MD, PhD Delafontaine Hospital
Study Director: Jean Marc Cavaillon, ScD Pasteur Institute
  More Information

No publications provided

Responsible Party: Christophe Adrie, Delafotaine Hospital
ClinicalTrials.gov Identifier: NCT00615225     History of Changes
Other Study ID Numbers: CCPPRB/114-02, Agence de Biomédecine 2005
Study First Received: February 4, 2008
Last Updated: February 13, 2008
Health Authority: France: Institutional Ethical Committee

Keywords provided by Delafontaine Hospital:
brain death
inflammation
endotoxin
transplantation
graft
apoptosis
Systemic inflammatory response
Apoptosis activation
Graft outcome

Additional relevant MeSH terms:
Brain Death
Death
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Coma
Unconsciousness
Consciousness Disorders
Neurobehavioral Manifestations
Neurologic Manifestations
Pathologic Processes

ClinicalTrials.gov processed this record on July 28, 2014